Operating Lease, Right-of-Use Asset of Phio Pharmaceuticals Corp. from 31 Dec 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Phio Pharmaceuticals Corp. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Dec 2024.
  • Phio Pharmaceuticals Corp. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Phio Pharmaceuticals Corp. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $0 -$33,000 -100% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $0 -$66,000 -100% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $0 -$98,000 -100% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $0 -$130,000 -100% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $33,000 -$128,000 -80% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $66,000 -$126,000 -66% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $98,000 -$125,000 -56% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $130,000 -$123,000 -49% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $161,000 -$122,000 -43% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $192,000 -$121,000 -39% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $223,000 -$119,000 -35% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $253,000 -$118,000 -32% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $283,000 -$117,000 -29% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $313,000 -$115,000 -27% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $342,000 -$114,000 -25% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $371,000 -$113,000 -23% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $400,000 -$111,000 -22% 31 Dec 2020 10-K 22 Mar 2022 2021 FY
Q3 2020 $428,000 -$110,000 -20% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $456,000 -$109,000 -19% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $484,000 -$108,000 -18% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $511,000 +$511,000 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 $538,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $565,000 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $592,000 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 26 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.